Wednesday, March 06, 2024 4:03:51 PM
The answer is...You were not randomized into the trial, as was the question asked. If what you say is even plausible, and I am sure that if all you said were true, which I very much doubt, you would have had to complete/sign an informed consent...so that you could be included in this treatment offer, "very latest NICE gold standard treatment". Guessing he spelled out NICE for you? And also told you about their involvement in approval of clinical trials in the UK?
If you did not sign an informed consent, then the onus is on you.
So you demanded an MRI, but did not sign an informed consent?? Hmmm..someone was going to open up your head and take out part of your brain and you did not sign an informed consent??
Yes, Nigel French is alive, because he was treated with DCVAX-L and had his Glioblastoma resected which allowed extraction of tumour cells etc...for the process of making his personalized vaccine.
Next.
If you did not sign an informed consent, then the onus is on you.
So you demanded an MRI, but did not sign an informed consent?? Hmmm..someone was going to open up your head and take out part of your brain and you did not sign an informed consent??
Yes, Nigel French is alive, because he was treated with DCVAX-L and had his Glioblastoma resected which allowed extraction of tumour cells etc...for the process of making his personalized vaccine.
Next.
I am an Investment Advisor and run my own Investment Advisory Firm. Any comments are my own and are not to be used as investment advice. I own shares in NWBO
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
